Cardiotoxicity Mitigation

Cardiotoxicity Mitigation is a therapeutic strategy within the domain of toxicity reduction that specifically targets the prevention, reduction, or management of drug-induced cardiac damage through pharmacological, genetic, or procedural interventions.

474

Publications

21.3K

Citations

3K

Authors

802

Institutions

Publications per year

2017–2026

243

Authors

3K

  1. RH
    Reid Hayward

    University of Northern Colorado, United States

    7 publications · 528 citations

    7

    h-index

  2. CM
    Carole M. Schneider

    University of Northern Colorado, United States

    7 publications · 528 citations

    7

    h-index

  3. SM
    Simon Ming‐Yuen Lee

    University of Macau, Macao SAR China

    5 publications · 179 citations

    5

    h-index

  4. OA
    Othman A. Al‐Shabanah

    King Saud University, Saudi Arabia

    5 publications · 422 citations

    5

    h-index

  5. CL
    Chia‐Ying Lien

    University of Northern Colorado, United States

    5 publications · 220 citations

    5

    h-index

1–5 of 3K

Venues

  1. PubMed

    Repository · 30 publications · 1.5K citations

    20

    h-index

  2. Oxidative Medicine and Cellular Longevity

    15 publications · 602 citations

    15

    h-index

  3. Life Sciences

    15 publications · 595 citations

    14

    h-index

  4. Cardiovascular Toxicology

    13 publications · 415 citations

    12

    h-index

  5. Food and Chemical Toxicology

    9 publications · 485 citations

    9

    h-index

1–5